J E Reseland - JoVE Visualize

Showing results (1-10 of 27) with videos related to

Pageof 3

Sort By:

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|July 8, 1999

[Leptin--a fatty tissue hormone with many functions]J E Reseland, K Hollung, C A Drevon

Current Pharmaceutical Design|March 20, 2001

Pharmacological interference with transcriptional control of osteoblasts: a possible role for leptin and fatty acids in maintaining bone strength and body lean massJ O Gordeladze, J E Reseland, C A Drevon

Osteoarthritis and Cartilage|May 29, 2016

Bone marrow lesions in hip osteoarthritis are characterized by increased bone turnover and enhanced angiogenesisM Shabestari, J Vik, J E Reseland, et al.

Acta Paediatrica (Oslo, Norway : 1992)|May 3, 2001

Smoking related to plasma leptin concentration in pregnant women and their newborn infantsI B Helland, J E Reseland, O D Saugstad, et al.

Pediatrics|March 11, 1998

Leptin levels in pregnant women and newborn infants: gender differences and reduction during the neonatal periodI B Helland, J E Reseland, O D Saugstad, et al.

The Journal of Nutrition|July 1, 1992

Raw soybeans stimulate human pancreatic proteinase secretionH Holm, J E Reseland, L I Thorsen, et al.

The Journal of Nutrition|March 1, 1996

Proteinase inhibitors induce selective stimulation of human trypsin and chymotrypsin secretionJ E Reseland, H Holm, M B Jacobsen, et al.

Clinical Rheumatology|October 19, 1999

Decreased CD4+ lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvationD A Fraser, J Thoen, J E Reseland, et al.

Scandinavian Journal of Gastroenterology|January 1, 1995

Inhibitor-stimulated non-parallel pancreatic secretion in man: hormonal and neural regulation?J E Reseland, H Holm, T Jenssen, et al.

Placenta|June 14, 2002

Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation?T Clausen, S Djurovic, J E Reseland, et al.

Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:

Pageof 3

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|July 8, 1999

[Leptin--a fatty tissue hormone with many functions]J E Reseland, K Hollung, C A Drevon

Current Pharmaceutical Design|March 20, 2001

Pharmacological interference with transcriptional control of osteoblasts: a possible role for leptin and fatty acids in maintaining bone strength and body lean massJ O Gordeladze, J E Reseland, C A Drevon

Osteoarthritis and Cartilage|May 29, 2016

Bone marrow lesions in hip osteoarthritis are characterized by increased bone turnover and enhanced angiogenesisM Shabestari, J Vik, J E Reseland, et al.

Acta Paediatrica (Oslo, Norway : 1992)|May 3, 2001

Smoking related to plasma leptin concentration in pregnant women and their newborn infantsI B Helland, J E Reseland, O D Saugstad, et al.

Pediatrics|March 11, 1998

Leptin levels in pregnant women and newborn infants: gender differences and reduction during the neonatal periodI B Helland, J E Reseland, O D Saugstad, et al.

The Journal of Nutrition|July 1, 1992

Raw soybeans stimulate human pancreatic proteinase secretionH Holm, J E Reseland, L I Thorsen, et al.

The Journal of Nutrition|March 1, 1996

Proteinase inhibitors induce selective stimulation of human trypsin and chymotrypsin secretionJ E Reseland, H Holm, M B Jacobsen, et al.

Clinical Rheumatology|October 19, 1999

Decreased CD4+ lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvationD A Fraser, J Thoen, J E Reseland, et al.

Scandinavian Journal of Gastroenterology|January 1, 1995

Inhibitor-stimulated non-parallel pancreatic secretion in man: hormonal and neural regulation?J E Reseland, H Holm, T Jenssen, et al.

Placenta|June 14, 2002

Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation?T Clausen, S Djurovic, J E Reseland, et al.

Pageof 3